0. Advocacy Graphic


  • February 12, 2019

    American College of Clinical Pharmacy Joins the Fight to Stop Opioid Overdose

    The Coalition to Stop Opioid Overdose is pleased to welcome the American College of Clinical Pharmacy (ACCP) to the coalition.
  • January 15, 2019

    The National Association for Behavioral Healthcare Joins the Fight to Stop Opioid Overdose

    The Coalition to Stop Opioid Overdose (CSOO) is thrilled to welcome the National Association for Behavioral Healthcare (NABH) as a new member of the coalition. NABH represents provider systems that are committed to the high-quality clinical care for people with mental health and substance use disorders.
  • January 10, 2019

    New Taxonomy Code

    Given the recognition of addiction medicine as a medical subspecialty by ABMS, with an established curriculum and training standards and a new certification pathway, ASAM believed it was timely and appropriate to request a new taxonomy code that would capture the distinctive nature of this area of specialty practice.
  • December 19, 2018

    ASAM Submits Comments to FDA Regarding Strategies to Increase Naloxone Availability

    ASAM submitted comments to the Food and Drug Administration (FDA) in response to a request for comment ahead of a public advisory committee meeting regarding strategies to increase the availability of naloxone products intended for use in the community.
  • December 18, 2018

    US Surgeon General Proclaims E-Cigarette Use an Epidemic Among Youth

    US Surgeon General Jerome M. Adams issued a rare public health Advisory declaring the use of e-cigarettes an “epidemic among our nation’s young people.” The Advisory provides information to parents, educators, and health professionals on new types of e-cigarettes on the market, including JUUL, and the negative health consequences of youth use of these products.
  • December 6, 2018

    ASAM Unveils National Public Policy Statement on Substance Use Prevention

    ASAM has released a set of evidence-informed policy recommendations for preventing alcohol and drug-related problems in contemporary society. The policy recommendations were approved by the ASAM Board of Directors and have been endorsed by the American College of Preventive Medicine.
  • October 24, 2018

    Addiction Medicine Leaders Applaud Signing of Historic Opioid Legislation into Law

    The leading association for addiction treatment professionals noted that while H.R. 6 is a critical step toward stemming the nation’s opioid overdose epidemic, more work remains to ensure that patients receive whole-person, evidence-based treatment for opioid use disorder.
  • October 3, 2018

    ASAM Applauds Senate Passage of Bipartisan Opioid Package

    Legislation is an Important Step Forward to Close the Addiction Treatment Gap and Teach, Standardize, and Cover Addiction Medicine